yohimbine has been researched along with Inflammation in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (11.76) | 18.2507 |
2000's | 6 (35.29) | 29.6817 |
2010's | 6 (35.29) | 24.3611 |
2020's | 3 (17.65) | 2.80 |
Authors | Studies |
---|---|
Fujimoto, Y; Juri, T; Mori, T; Nishikawa, K; Suehiro, K | 1 |
Chen, Z; Deng, Q; Huang, W; Qiu, Y; Shen, J; Wen, S; Zhan, Y | 1 |
He, Y; Huang, Y; Liao, G; Ou, F; Su, K; Sun, J; Tang, D; Zeng, R | 1 |
Lin, B; Lu, Y; Zhong, J | 1 |
Chen, H; Hou, Y; Liu, D; Sun, X; Wang, H; Wang, Y; Wu, J; Yang, X; Yi, W; Yu, J; Yu, X | 1 |
Higuchi, H; Inoue, M; Maeda, S; Miyawaki, T; Nagatsuka, H; Sukegawa, S | 1 |
Li, H; Wang, Y; Wang, Z; Zhang, J; Zhou, G | 1 |
Hagiwara, S; Iwasaka, H; Noguchi, T; Takeshima, N | 1 |
Holden, JE; Jeong, Y | 1 |
Dong, R; Feng, X; Li, W; Liu, J; Wang, H; Xu, J; Yu, B; Zhang, F | 1 |
Micov, AM; Paranos, SLj; Stepanović-Petrović, RM; Tomić, MA | 1 |
Boskovic, B; Prostran, M; Stepanović-Petrovic, R; Tomić, M; Ugresic, N; Vuckovic, S | 1 |
Hiruma, Y; Matsui, Y; Matsutani, K; Tsuruoka, M | 1 |
Dickenson, AH; Green, GM; Lyons, L | 1 |
Kawamata, M; Kawamata, T; Namiki, A; Omote, K; Sonoda, H | 1 |
Capasso, F; Capasso, R; Di Marzo, V; Fezza, F; Izzo, AA; Mascolo, N; Pinto, A | 1 |
Matsushima, K; Tozawa, Y | 1 |
17 other study(ies) available for yohimbine and Inflammation
Article | Year |
---|---|
Participation of the descending noradrenergic inhibitory system in the anti-hyperalgesic effect of acetaminophen in a rat model of inflammation.
Topics: Acetaminophen; Animals; Carrageenan; Disease Models, Animal; Hyperalgesia; Inflammation; Locus Coeruleus; Male; Norepinephrine; Rats; Rats, Sprague-Dawley; Spinal Cord; Yohimbine | 2021 |
DEXMEDETOMIDINE PREVENTS PDIA3 DECREASE BY ACTIVATING α2-ADRENERGIC RECEPTOR TO ALLEVIATE INTESTINAL I/R IN MICE.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Apoptosis; Dexmedetomidine; Inflammation; Mice; Mice, Inbred C57BL; Protein Disulfide-Isomerases; Receptors, Adrenergic, alpha-2; Yohimbine | 2022 |
Yohimbine Ameliorates Temporomandibular Joint Chondrocyte Inflammation with Suppression of NF-κB Pathway.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Cells, Cultured; Chondrocytes; Inflammation; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Signal Transduction; Temporomandibular Joint; Temporomandibular Joint Disorders; Yohimbine | 2021 |
The Therapeutic Effect of Dexmedetomidine on Rat Diabetic Neuropathy Pain and the Mechanism.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Apoptosis; Cytokines; Dexmedetomidine; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Glutamic Acid; Hyperalgesia; Inflammation; Interleukin-1beta; Male; Microglia; Pain Threshold; Rats, Sprague-Dawley; Spinal Cord; Tumor Necrosis Factor-alpha; Yohimbine | 2017 |
Dexmedetomidine reduces ventilator-induced lung injury (VILI) by inhibiting Toll-like receptor 4 (TLR4)/nuclear factor (NF)-κB signaling pathway.
Topics: Animals; Bronchoalveolar Lavage Fluid; Cytokines; Dexmedetomidine; Humans; Inflammation; Lung; Male; NF-kappa B; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Signal Transduction; Toll-Like Receptor 4; Ventilator-Induced Lung Injury; Yohimbine | 2018 |
Locally injected dexmedetomidine inhibits carrageenin-induced inflammatory responses in the injected region.
Topics: Adrenergic alpha-2 Receptor Antagonists; Anesthetics; Animals; Anti-Inflammatory Agents; Carrageenan; Cyclooxygenase 2; Dexmedetomidine; Edema; Immunohistochemistry; Inflammation; Leukocytes; Male; Mice; Receptors, Adrenergic, alpha-2; Time Factors; Tumor Necrosis Factor-alpha; Yohimbine | 2014 |
The effect of dexmedetomidine on inflammatory response of septic rats.
Topics: Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Cytokines; Dexmedetomidine; Enzyme-Linked Immunosorbent Assay; Inflammation; Interleukin-6; Ligation; Male; MAP Kinase Signaling System; Myeloid Differentiation Factor 88; NF-kappa B; Random Allocation; Rats, Sprague-Dawley; Sepsis; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha; Yohimbine | 2015 |
Mechanisms of analgesic action of pulsed radiofrequency on adjuvant-induced pain in the rat: roles of descending adrenergic and serotonergic systems.
Topics: Adrenergic alpha-Antagonists; Analgesia; Animals; Brain Stem; Catecholamines; Catheter Ablation; Disease Models, Animal; Efferent Pathways; Freund's Adjuvant; Inflammation; Male; Neural Inhibition; Nociceptors; Pain; Pain Management; Rats; Rats, Sprague-Dawley; Sciatic Neuropathy; Serotonin; Serotonin Antagonists; Treatment Outcome; Tropanes; Yohimbine | 2009 |
Lateral hypothalamic-induced alpha-adrenoceptor modulation occurs in a model of inflammatory pain in rats.
Topics: Adrenergic alpha-Antagonists; Animals; Carbachol; Cholinergic Agonists; Disease Models, Animal; Female; Hypothalamic Area, Lateral; Inflammation; Isothiocyanates; Nociceptors; Nursing Research; Pain; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Adrenergic, alpha; Tarsus, Animal; Yohimbine | 2009 |
Effects of clonidine on bilateral pain behaviors and inflammatory response in rats under the state of neuropathic pain.
Topics: Adrenergic alpha-2 Receptor Antagonists; Analgesics; Analysis of Variance; Animals; Clonidine; Cytokines; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Functional Laterality; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Hyperalgesia; Inflammation; Macrophage-1 Antigen; Male; Pain Threshold; Physical Stimulation; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sciatica; Time Factors; Yohimbine | 2011 |
The mechanisms of antihyperalgesic effect of topiramate in a rat model of inflammatory hyperalgesia.
Topics: Analgesics; Animals; Bicuculline; Carrageenan; Disease Models, Animal; Dose-Response Relationship, Drug; Fructose; Hyperalgesia; Inflammation; Male; Naloxone; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Receptors, GABA-A; Receptors, Opioid; Topiramate; Yohimbine | 2013 |
Role of alpha2-adrenoceptors in the local peripheral antinociception by carbamazepine in a rat model of inflammatory mechanical hyperalgesia.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Analgesics, Non-Narcotic; Animals; Carbamazepine; Concanavalin A; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Hindlimb; Hyperalgesia; Inflammation; Injections; Male; Pain; Pain Measurement; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Time Factors; Yohimbine | 2007 |
Effects of yohimbine on naloxone-induced antinociception in a rat model of inflammatory hyperalgesia.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Carrageenan; Hyperalgesia; Inflammation; Injections, Intraperitoneal; Male; Naloxone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Yohimbine | 1998 |
Alpha2-adrenoceptor antagonists enhance responses of dorsal horn neurones to formalin induced inflammation.
Topics: Adrenergic alpha-Antagonists; Animals; Electric Stimulation; Formaldehyde; Idazoxan; Imidazoles; Inflammation; Male; Neurons; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Spinal Cord; Yohimbine | 1998 |
Analgesic mechanisms of ketamine in the presence and absence of peripheral inflammation.
Topics: Adrenergic alpha-Antagonists; Analgesia; Analgesics; Animals; Carrageenan; Drug Administration Schedule; Drug Interactions; Hot Temperature; Hyperalgesia; Inflammation; Injections, Intraperitoneal; Injections, Spinal; Ketamine; Male; Methysergide; Microdialysis; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents; Yohimbine | 2000 |
Inhibitory effect of palmitoylethanolamide on gastrointestinal motility in mice.
Topics: Adrenergic alpha-Antagonists; Amides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Camphanes; Croton Oil; Dose-Response Relationship, Drug; Endocannabinoids; Enzyme Inhibitors; Ethanolamines; Gastrointestinal Motility; Gastrointestinal Transit; Hexamethonium; Inflammation; Intestine, Small; Male; Mice; Mice, Inbred ICR; Naloxone; NG-Nitroarginine Methyl Ester; Nicotinic Antagonists; Nitric Oxide Synthase; Palmitic Acids; Phenylmethylsulfonyl Fluoride; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Yohimbine | 2001 |
Peripheral 5-HT(2A)-receptor-mediated formation of an inhibitor of atrial natriuretic peptide binding involves inflammation.
Topics: Adrenergic alpha-Antagonists; alpha-Methyltyrosine; Animals; Atrial Natriuretic Factor; Catecholamines; Cyclooxygenase Inhibitors; Dexamethasone; Ditiocarb; Dopamine beta-Hydroxylase; Dose-Response Relationship, Drug; Endothelium, Vascular; Humans; Indomethacin; Inflammation; Isatin; Ketanserin; Muscle, Smooth; Prazosin; Propranolol; Protein Binding; Rats; Rats, Wistar; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, Serotonin, 5-HT2A; Receptors, Angiotensin; Receptors, Serotonin; Reserpine; Ritanserin; Serotonin; Serotonin Receptor Agonists; Tyrosine 3-Monooxygenase; Urination; Vascular Resistance; Yohimbine | 2002 |